Genetic Technologies Ltd. Daily Stock Analysis

Daily Stock Analysis, GENE, Genetic Technologies Ltd, priceseries

Genetic Technologies Ltd. Daily Stock Analysis
Stock Information
Open
1.93
Close
1.90
High
1.98
Low
1.90
Previous Close
1.95
Daily Price Gain
-0.05
YTD High
2.12
YTD High Date
Feb 10, 2022
YTD Low
1.70
YTD Low Date
Jan 31, 2022
YTD Price Change
-0.13
YTD Gain
-6.40%
52 Week High
5.74
52 Week High Date
Apr 9, 2021
52 Week Low
1.70
52 Week Low Date
Jan 31, 2022
52 Week Price Change
-2.21
52 Week Gain
-53.77%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 19. 2017
3.88
Dec 22. 2017
4.42
3 Trading Days
13.94%
Link
LONG
Jan 4. 2018
4.72
Feb 15. 2018
6.49
18 Trading Days
37.59%
Link
LONG
Apr 9. 2018
4.72
Apr 23. 2018
5.10
10 Trading Days
8.14%
Link
LONG
Jul 13. 2018
4.36
Jul 24. 2018
5.01
7 Trading Days
14.91%
Link
LONG
Jan 4. 2019
2.60
Jan 30. 2019
3.30
17 Trading Days
26.85%
Link
LONG
Jan 6. 2020
2.08
Jan 29. 2020
3.94
16 Trading Days
89.30%
Link
LONG
Mar 26. 2020
1.90
Mar 27. 2020
2.00
1 Trading Days
5.26%
Link
LONG
Mar 30. 2020
1.95
Apr 1. 2020
2.36
2 Trading Days
21.28%
Link
LONG
Dec 7. 2020
3.26
Dec 10. 2020
3.56
3 Trading Days
9.28%
Link
LONG
Feb 12. 2021
4.86
Feb 22. 2021
5.16
5 Trading Days
6.17%
Link
LONG
Apr 28. 2021
4.20
Apr 29. 2021
4.44
1 Trading Days
5.71%
Link
Company Information
Stock Symbol
GENE
Exchange
NasdaqCM
Company URL
http://www.gtglabs.com
Company Phone
011613-9415-1135
CEO
Eutillio Buccilli
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001166272
About

Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Description

Genetic Technologies Limited operates as a life science company, specializing in the fields of genetics and genomics primarily in Australia. The company provides genetic testing services to human beings for disease susceptibility, parentage, individual identity, forensics, and sports performance; animals, such as dogs, horses, birds, alpacas, exotics, and zoo animals for parentage, pedigree, traits, and disease susceptibility; and plants for traits and disease susceptibility. It also offers canine reproductive services, as well as involves in licensing its non-coding DNA patents. In addition, the company offers BREVAGen, a diagnostic test that informs clinicians and patients about individual, non-familial, sporadic risk of breast cancer for women where a breast biopsy outcome is indeterminate. The company was formerly known as Duketon Goldfields N.L. and changed its name to Genetic Technologies Limited in August 2000. Genetic Technologies Limited was incorporated in 1987 and is based in Fitzroy, Australia.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading